Dr. Barry Dworkin

mRNA-derived pancreatic cancer vaccine demonstrates efficacy in small study. Much more evaluation required for these bespoke vaccines.

Medical Mythbusting Commentary for March 17, 2025

Source:
Pancreatic cancer vaccine shows hope. Make the investment.

Reference:
RNA vaccine induces long-lived anti-tumour T cells in pancreatic cancer

Related posts:

  1. Pancreatic Cancer Vaccine Shows Promise in Small Trial
  2. Pancreatic cancer research given a boost
  3. New biotherapeutic cancer treatment centre an excellent addition to novel therapeutic solutions
  4. Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can’t do it.